Related Concept Videos
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
RACE - Rapid Amplification of cDNA Ends
RNA Editing
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Anaphase Promoting Complex
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
A mammalian genomic signature shaped by single nucleotide variants regulates transcriptome integrity and diversity.
Integrating whole genome and transcriptome sequencing to characterize the genetic architecture of isoform variation.
A Mammalian Genomic Signature Shaped by Single Nucleotide Variants Controlling Transcriptome Integrity and Diversity.
Integrating Whole Genome and Transcriptome Sequencing to Characterize the Genetic Architecture of Isoform Variation and its Implications for Health and Disease.
Genetic excision of the regulatory cardiac troponin I extension in high-heart rate mammal clades.
Epigenetic control of adaptive or homeostatic splicing during interval-training activities.
The Nuclear Export Signal of IκBα Drives RelB Oscillations in the Noncanonical NF-κB Pathway.
The SQSTM1 L341V Variant Associated With Sporadic ALS Promotes the Accumulation of Enlarged Ubiquitin-Positive SQSTM1 Bodies.
Partial Depletion of SART1 Selectively Induces Mitotic Defects and Cell Death in Cancer Cells.
FOXO1 Is Required for Growth and Viability of Cancer-Associated Fibroblasts in Human Breast Carcinomas.
Strain-Dependent Functional Variation of a Sex Specific Sox9 Enhancer.
An Outflow Tract Myocardium-Specific Enhancer at the Sema3c Locus During Heart Development.
Related Experiment Video
Updated: Mar 11, 2026

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
Published on: July 7, 2023
5-Aza-Cytidine Enhances Terminal Polyadenylation Site Usage for Full-Length Transcripts in Cells.
Samuel Ogunsola1, Ling Liu1, Urmi Das1
1Department of Physiology & Pathophysiology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
The anti-cancer drug 5-aza-cytidine (5-azaC) promotes full-length mRNA production by shifting polyadenylation to genomic terminal exons (GTEs). This reveals a new mechanism of 5-azaC
Area of Science:
- Molecular Biology
- Cancer Research
- Genomics
Background:
- 5-aza-cytidine (5-azaC) is an anti-cancer drug that inhibits DNA methyltransferases (DNMTs).
- The precise effects of 5-azaC on gene expression, particularly mRNA processing, are not fully understood.
Purpose of the Study:
- To investigate the impact of 5-azaC on mRNA polyadenylation and transcript length.
- To elucidate the mechanisms by which 5-azaC influences gene expression in cancer cells.
Main Methods:
- Treatment of cultured GH3 pituitary tumor cells and MOLM-13 leukemia cells with 5-azaC.
- Analysis of mRNA polyadenylation site usage and alternative polyadenylation factors via transcriptomic analysis.
- Examination of the expression levels of mRNA processing factors like Scaf4, Scaf8, E2f2, and PCF11.
Main Results:
- 5-azaC treatment increases the relative usage of genomic terminal exons (GTEs) across the transcriptome.
- This shift in polyadenylation from proximal sites to GTEs leads to the production of full-length transcripts.
- 5-azaC upregulates anti-termination factors (Scaf4, Scaf8) and downregulates an early termination enhancer (E2f2).
- PCF11, a proximal poly(A) site factor, is upregulated, suggesting a cellular response to counteract transcript lengthening.
Conclusions:
- 5-azaC promotes terminal polyadenylation site usage, leading to a transcriptome-wide switch from shortened to full-length mRNAs.
- This mechanism alters alternative 3' exon usage in tumor and cancer cells.
- Uncovers a novel effect of 5-azaC on gene expression beyond DNMT inhibition.

